Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Josh B. Karpes"'
Publikováno v:
Anticancer Research. 41:1641-1646
Background/aim Cisplatin increases the risk of acute kidney injury (AKI) during systemic chemotherapy. However, little is known about its risk of inducing AKI when used during intraperitoneal chemotherapy. This study aimed to determine the incidence
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c16f8220284566f0be88f784ead4beb4
https://doi.org/10.21873/anticanres.14926
https://doi.org/10.21873/anticanres.14926
Publikováno v:
Anticancer research. 42(6)
The aim of the study was to determine outcomes and overall survival (OS) in patients undergoing cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC) for malignant peritoneal mesothelioma (MPM).This was a retrospective cohort st
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::44aea936579c23460d98e7d5e4b29273
https://pubmed.ncbi.nlm.nih.gov/35641285
https://pubmed.ncbi.nlm.nih.gov/35641285
Publikováno v:
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 47(1)
To determine the effect of signet ring cell (SRC) histopathology in appendix cancer with peritoneal dissemination on overall survival (OS) in patients undergoing cytoreductive surgery (CRS) and heated intraperitoneal chemotherapy (HIPEC).Retrospectiv
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::debc5312d020453c287448db5c81380b
https://pubmed.ncbi.nlm.nih.gov/33272738
https://pubmed.ncbi.nlm.nih.gov/33272738
Autor:
Joshua Lansom, David L. Morris, Winston Liauw, Nayef A. Alzahrani, Josh B. Karpes, Mohammad S. Alshahrani, R. Shamavonian, Roneil Parikh
Publikováno v:
BJS Open
BJS Open, Vol 4, Iss 3, Pp 478-485 (2020)
BJS Open, Vol 4, Iss 3, Pp 478-485 (2020)
Background With recurrence rates after primary cytoreductive surgery (CRS) in excess of 50 per cent, repeat CRS is being performed increasingly, but survival outcomes have not been reported widely. This study examined the outcomes following repeat CR
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::82b6e1cd0eff6050ef42b029c5c951b1
https://pubmed.ncbi.nlm.nih.gov/32020757
https://pubmed.ncbi.nlm.nih.gov/32020757
Autor:
David L. Morris, Daniel M. Dotta, Nayef A. Alzahrani, Raphael Shamavonian, Josh B. Karpes, Oliver M. Fisher
Publikováno v:
Journal of Clinical Oncology. 37:e15704-e15704
e15704 Background: Completeness of cytoreduction score (CC-score) and tumour volume (as expressed by the peritoneal cancer index (PCI)) have been demonstrated as important post-operative prognostic factors in those patients with appendix cancer with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ae2e4d189c86288f5f9ddc7a2d911150
https://doi.org/10.1200/jco.2019.37.15_suppl.e15704
https://doi.org/10.1200/jco.2019.37.15_suppl.e15704
Publikováno v:
Journal of Clinical Oncology. 37:e15702-e15702
e15702 Background: CRS/HIPEC has been established as the method of choice for the management of peritoneal dissemination from appendiceal cancer. With recurrence rates after first surgery as high as 44%, re-do CRS/HIPEC is evolving as an effective re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3580795cc2b11e412a200c08af9dcd19
https://doi.org/10.1200/jco.2019.37.15_suppl.e15702
https://doi.org/10.1200/jco.2019.37.15_suppl.e15702